HomeOrderingContact UsAbout UsInvestor InformationSite Map
FCW 200 WAVE Fragment Collector

The Transgenomic WAVE® Fragment Collector Model FCW 200 enables fully automated purification of nucleic acids with the WAVE System. Nucleic acid samples collected by the FCW 200 meet high purity and sample concentration requirements for use in molecular genetic analyses and genomics. The dual plate FCW 200 enables fully automated fractionation and purification of ss- and dsDNA, RNA, and synthetic oligonucleotides with minimum sample loss and minimum cross contamination.

The FCW 200 is controlled by both NAVIGATOR™ Software and WAVEMAKER™ Software enabling multiple modes for collection of nucleic acid fragments including:

  • Minimum detection threshold above baseline with proprietary baseline drift compensation
  • Time/eluant volume window around peak retention time
  • Combined peak and threshold detection
  • Positive and/or negative slope detection
  • Combined slope and threshold detection
  • User-defined collection time windows

Design refinements in the FCW 200 include a proprietary flow drop control system that delivers:

  • Minimum sample loss
  • Minimum cross contamination
  • Precise drop volume control
  • Maximum sample concentration

The WAVE System with the optional Fragment Collector FCW 200 is a robust reliable system for the fractionation and purification of ss- and ds-DNA, RNA and synthetic oligonucleotides.

Screen shot of Navigator Fragment Collection software.

Screen Shot

Request a quote for this accessory.

 

 
Abstract - Somatic mosaicism in a patient with Lynch syndrome
Abstract - Development of a denaturing high-performance liquid chromatography method for detection of protist parasites of metazoans
Abstract - Rapid identification of mitochondrial DNA (mtDNA) mutations in neuromuscular disorders by using surveyor strategy
Feb 3 Press Releases
Transgenomic Announces $22.0 Million Private Placement Financing
Jan 9 Press Releases
Transgenomic, Inc. and Power3 Medical Products, Inc. Resolve All Outstanding Litigation Proceedings and Disputes
Jan 6 Press Releases
Transgenomic Announces $3 Million Convertible Note Financing
 
Contact WebmasterSend Page To ColleaguePrintable PageChange Country United States
Copyright © 1997-2012 Transgenomic, Inc., All Rights Reserved.the power of discovery™